Response Monitoring with [
Autor: | Sandra, Heskamp, Linda, Heijmen, Danny, Gerrits, Janneke D M, Molkenboer-Kuenen, Edwin G W, Ter Voert, Kathrin, Heinzmann, Davina J, Honess, Donna-Michelle, Smith, John R, Griffiths, Sabrina, Doblas, Ralph, Sinkus, Peter, Laverman, Wim J G, Oyen, Arend, Heerschap, Otto C, Boerman |
---|---|
Rok vydání: | 2016 |
Předmět: |
Tomography
Emission-Computed Single-Photon Response monitoring Cell Death 5-Fluorouracil Liver Neoplasms Diffusion-weighted MRI Immunohistochemistry Colorectal cancer Dideoxynucleosides Rats Disease Models Animal Diffusion Magnetic Resonance Imaging Treatment Outcome Cell Line Tumor Positron-Emission Tomography Animals Fluorouracil [18F]FLT PET Colorectal Neoplasms Tomography X-Ray Computed Cell Proliferation Research Article |
Zdroj: | Molecular Imaging and Biology |
ISSN: | 1860-2002 |
Popis: | Purpose The aim of the study was to investigate the potential of diffusion-weighted magnetic resonance imaging (DW-MRI) and 3′-dexoy-3′-[18F]fluorothymidine ([18F]FLT) positron emission tomography (PET) as early biomarkers of treatment response of 5-fluorouracil (5-FU) in a syngeneic rat model of colorectal cancer liver metastases. Procedures Wag/Rij rats with intrahepatic syngeneic CC531 tumors were treated with 5-FU (15, 30, or 60 mg/kg in weekly intervals). Before treatment and at days 1, 3, 7, and 14 after treatment rats underwent DW-MRI and [18F]FLT PET. Tumors were analyzed immunohistochemically for Ki67, TK1, and ENT1 expression. Results 5-FU inhibited the growth of CC531 tumors in a dose-dependent manner. Immunohistochemical analysis did not show significant changes in Ki67, TK1, and ENT1 expression. However, [18F]FLT SUVmean and SUVmax were significantly increased at days 4 and 7 after treatment with 5-FU (60 mg/kg) and returned to baseline at day 14 (SUVmax at days −1, 4, 7, and 14 was 1.1 ± 0.1, 2.3 ± 0.5, 2.3 ± 0.6, and 1.5 ± 0.4, respectively). No changes in [18F]FLT uptake were observed in the nontreated animals. Furthermore, the apparent diffusion coefficient (ADCmean) did not change in 5-FU-treated rats compared to untreated rats. Conclusion This study suggests that 5-FU treatment induces a flare in [18F]FLT uptake of responsive CC531 tumors in the liver, while the ADCmean did not change significantly. Future studies in larger groups are warranted to further investigate whether [18F]FLT PET can discriminate between disease progression and treatment response. Electronic supplementary material The online version of this article (doi:10.1007/s11307-016-1021-2) contains supplementary material, which is available to authorized users. |
Databáze: | OpenAIRE |
Externí odkaz: |